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Entering weightlessness (0 G) induces immediately a shift of blood and fluid from the lower to 
the upper parts of the body inducing expansion of the cardiac chambers (Bungo et al. 1986; 
Charles & Lathers 1991; Videbaek & Norsk 1997). For many years the effects of sudden 0 G on 
central venous pressure (CVP) was discussed, and it puzzled researchers that CVP compared to 
the 1-G supine position decreased during the initial hours of spaceflight, when at the same time 
left atrial diameter increased (Buckey et al. 1996). By measuring esophageal pressure as an 
estimate of inter-pleural pressure, it was later shown that this pressure decreases more than CVP 
does during 0 G induced by parabolic flights (Videbaek & Norsk 1997). Thus, transmural CVP is 
increased, which distends the cardiac chambers. This unique lung-heart interaction whereby 1) 
inter-pleural pressure decreases and 2) central blood volume is expanded is unique for 0 G. 
Because transmural CVP is increased, stroke volume increases according to the law of Frank-
Starling leading to an increase in cardiac output, which is maintained increased during months of 
0 G in space to levels of some 25 % above that of the 1-G seated position (Norsk unpublished). 
Simultaneously, sympathetic nervous activity is at the level of the upright 1-G posture, which is 
difficult to explain based on the high stroke volume and decreased blood pressure and systemic 
vascular resistance. This paradox should be explored and the mechanisms revealed, because it 
might have implications for estimating the cardiovascular risk of travelling in space. 
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Background
Short-term spaceflight (< 2 weeks):
Variable Method Effect References
(0 G/upright)
_______________________________________________________________________________________________________
Blood pressure (BP) 24-h Brachial Meck et al.
(Oscillometry) (Only DAP) (J. Appl. Physiol. 1996)
Brachial (Auscultatory/ Shykoff et al.
oscillometry) (J. Appl. Physiol. 1996)
Finger (infrared
photoplethysmography) Norsk et al.
(Hypertension 2006)
______________________________________________________________________________________________________
Cardiac output (CO) Rebreathing Prisk et al.
(Acetylene) (J. Appl. Physiol. 1993)
Rebreathing Norsk et al.
(N2O) (Hypertension 2006)
Rebreathing Shykoff et al.
(CO2) (J. Appl. Physiol. 1996)
______________________________________________________________________________________________________
Systemic vascular resistance MAP/CO Shykoff et al.
(J. Appl. Physiol. 1996)











Short-term spaceflight (< 2 weeks):
Variable Method Effect References
(0 G/upright)
_______________________________________________________________________________________________________
Blood pressure (BP) 24-h Brachial Meck et al.
(Oscillometry) (Only DAP) (J. Appl. Physiol. 1996)
Brachial (Auscultatory/ Shykoff et al.
oscillometry) (J. Appl. Physiol. 1996)
Finger (infrared
photoplethysmography) Norsk et al.
(Hypertension 2006)
______________________________________________________________________________________________________
Cardiac output (CO) Rebreathing Prisk et al.
(Acetylene) (J. Appl. Physiol. 1993)
Rebreathing Norsk et al.
(N2O) (Hypertension 2006)
Rebreathing Shykoff et al.
(CO2) (J. Appl. Physiol. 1996)
______________________________________________________________________________________________________
Systemic vascular resistance MAP/CO Shykoff et al.
(J. Appl. Physiol. 1996)








Short-term spaceflight (< 2 weeks):
Variable Method Effect References
(0 G/upright)
_______________________________________________________________________________________________________
Blood pressure (BP) 24-h Brachial Meck et al.
(Oscillometry) (Only DAP) (J. Appl. Physiol. 1996)
Brachial (Auscultatory/ Shykoff et al.
oscillometry) (J. Appl. Physiol. 1996)
Finger (infrared
photoplethysmography) Norsk et al.
(Hypertension 2006)
______________________________________________________________________________________________________
Cardiac output (CO) Rebreathing Prisk et al.
(Acetylene) (J. Appl. Physiol. 1993)
Rebreathing Norsk et al.
(N2O) (Hypertension 2006)
Rebreathing Shykoff et al.
(CO2) (J. Appl. Physiol. 1996)
______________________________________________________________________________________________________
Systemic vascular resistance MAP/CO Shykoff et al.
(J. Appl. Physiol. 1996)































Long-term spaceflight (> 3 months):
Variable Method Effect References
(0 G/upright)
________________________________________________________________________________
Blood pressure (BP) Brachial or finger ? (Only DAP) Baevsky et al.




Long-term spaceflight (> 3 months):
Variable Method Effect References
(0 G/semi-upright)
________________________________________________________________________________
Blood pressure (BP) Brachial or finger ? (Only DAP) Baevsky et al.




To investigate how 24-h ambulatory blood
pressure and the cardiovascular system adapt to 
long-term (3-6 months) space flight and thus, 
how the daily load of gravity here on Earth
affects our ambulatory blood pressure.
Hypothesis
Despite an increase in cardiac output (CO), 24-h 
ambulatory brachial blood pressure (BP) is 
unchanged or decreased by chronic systemic 
arterial vasodilatation during long-term (months) 
space flight.
Paoli Nespoli






















Pre-flight: Launch minus 2 months or more
In-flight: Launch + 3 to 6 months
Post-flight: Landing + 2 months or more.
_____________________________________________________________________
Time: 12:00      16:00      20:00      24:00      04:00      08:00      12:00
14:00      18:00      22:00      02:00      06:00      10:00
_____________________________________________________________________
Blood pressure: X X X X X X X X X X X     X     X     X     X     X X X X X
(Ambulatory)
Cardiac output: X            X             X                                            X           X
(Seated)
Blood sampling:                                                                                              X
(Seated)
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HR = 62 3
(bpm)
HR = 67 4
(bpm)
*



































NE = 0.72 0.17
(ng·ml-1)
NE = 0.69 0.11
(ng·ml-1)
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Months of space flight on the ISS:
• 24-h ambulatory BP
• SV and thus CO
• Systemic vascular resistance
• SNA




stimulation by increased central blood
volume (increased SV and thus CO).
But what about the high SNA?
Exercise training effect? 
But HR and plasma NE unchanged!
High salt intake?
But 24-h renal Na+ excretion
unchanged!
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